SEATTLE — Many health care providers across the United States may be reluctant to prescribe an increasingly important prevention approach to some of their patients who are at substantial ongoing risk for HIV.

The quarterly HIV Specialist magazine of the American Academy of HIV Medicine published these survey results: “Providers’ Perspectives on Prescribing Pre-exposure Prophylaxis for HIV Prevention.”

Pre-exposure prophylaxis (PrEP) involves proactively prescribing a regimen of an HIV antiviral medication to people who do not have HIV. The medication helps prevent HIV from establishing itself and multiplying in the body.

Continue Reading

READ FULL ARTICLE Curated publisher From EurekAlert